Mass Spectrometry as a Highly Sensitive Method for Specific Circulating Tumor DNA Analysis in NSCLC: A Comparison Study

SIMPLE SUMMARY: We compared the UltraSEEK™ Lung Panel on the MassARRAY(®) System (Agena Bioscience) with the FDA-approved Cobas(®) EGFR Mutation Test v2 for the detection of EGFR mutations in liquid biopsies of NSCLC patients, accompanied with preanalytical sample assessment using the novel Liquid I...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamy, Pierre-Jean, van der Leest, Paul, Lozano, Nicolas, Becht, Catherine, Duboeuf, Frédérique, Groen, Harry J. M., Hilgers, Werner, Pourel, Nicolas, Rifaela, Naomi, Schuuring, Ed, Alix-Panabières, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602843/
https://www.ncbi.nlm.nih.gov/pubmed/33081150
http://dx.doi.org/10.3390/cancers12103002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602843/
https://www.ncbi.nlm.nih.gov/pubmed/33081150
http://dx.doi.org/10.3390/cancers12103002

Ejemplares similares